Jun Xia
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Drug Discovery top 10%
Papers in
-
- MicroRNA in disease regulation 13
-
- Glycosylation and Glycoproteins Research 9
- Mechanisms of cancer metastasis 4
- Co-authors
- Jia Ma (18 shared papers)Zhiwei Peter Wang (13 shared papers)Jing Du (13 shared papers)Zhiwei Wang (8 shared papers)Lucio Miele (6 shared papers)Yanchun Li (7 shared papers)Fanpeng Zeng (5 shared papers)Fazlul H. Sarkar (6 shared papers)
- Journals
- Journal of Clinical Laboratory Analysis (3 papers)Current Drug Targets (3 papers)Molecular Therapy — Nucleic Acids (2 papers)Cell Death Discovery (2 papers)Cell Death and Disease (2 papers)
- Partner nations
- ChinaUnited StatesIsrael
In The Last Decade
Jun Xia
66 papers receiving 2.1k citations
Jun Xia's Hit Papers
Peers
Comparison fields: 5 of 85
- Cancer Research 438
- Drug Discovery 6
- Molecular Medicine 124
- Pulmonary and Respiratory Medicine 367
- Molecular Biology 695
Countries citing papers authored by Jun Xia
This map shows the geographic impact of Jun Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Xia more than expected).
Fields of papers citing papers by Jun Xia
This network shows the impact of papers produced by Jun Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Xia. The network helps show where Jun Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 197 | |
| 2 | 2020 | 160 | |
| 3 | 2014 | 122 | |
| 4 | 2012 | 119 | |
| 5 | 2020 | 113 | |
| 6 | 2020 | 112 | |
| 7 | 2013 | 102 | |
| 8 | 2011 | 95 | |
| 9 | 2021 | 90 | |
| 10 | 2014 | 72 | |
| 11 | Targeting epigenetic and post-translational modifications of NRF2: key regulatory factors in disease treatment Hit paper breakdown → | 2025 | 67 |
| 12 | 2017 | 51 | |
| 13 | 2018 | 51 | |
| 14 | 2019 | 51 | |
| 15 | 2012 | 48 | |
| 16 | 2015 | 45 | |
| 17 | 2013 | 41 | |
| 18 | Synergistic reversal effect of epithelial-to-mesenchymal transition by miR-223 inhibitor and genistein in gemcitabine-resistant pancreatic cancer cells. | 2016 | 41 |
| 19 | 2021 | 40 | |
| 20 | 2005 | 37 |
About Jun Xia
Jun Xia is a scholar working on Cancer Research, Molecular Biology, Oncology, Pulmonary and Respiratory Medicine and Molecular Medicine, having authored 68 papers that have together received 2.2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (13 papers), Glycosylation and Glycoproteins Research (9 papers), Ferroptosis and cancer prognosis (6 papers), Clinical Laboratory Practices and Quality Control (5 papers), Cancer-related Molecular Pathways (5 papers), Mechanisms of cancer metastasis (4 papers), Curcumin's Biomedical Applications (3 papers) and Analytical chemistry methods development (3 papers). The work is most often cited by research in Cancer Research (438 citations), Drug Discovery (6 citations), Molecular Medicine (124 citations), Pulmonary and Respiratory Medicine (367 citations) and Molecular Biology (695 citations). Jun Xia has collaborated with scholars based in China, United States and Israel. Frequent co-authors include Jia Ma, Zhiwei Peter Wang, Jing Du, Zhiwei Wang, Lucio Miele, Yanchun Li, Fanpeng Zeng, Fazlul H. Sarkar, Long Cheng and Zhiwen Chen. Their work appears in journals such as Journal of Clinical Laboratory Analysis, Current Drug Targets, Molecular Therapy — Nucleic Acids, Cell Death Discovery and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.